
Alert: Rating Downgrade (4/8/24)-Takeda Pharmaceutical Co Ltd (NYSE: TAK).
Stock Rating Downgrade The Value Trend Rating for Takeda Pharmaceutical Co Ltd (NYSE: TAK) weakened of late from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included […]